Report overview
This report contains market size and forecasts of Small Molecule Targeted Anti-cancer Drug in Global, including the following market information:
Global Small Molecule Targeted Anti-cancer Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Small Molecule Targeted Anti-cancer Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
EGFR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Targeted Anti-cancer Drug include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Small Molecule Targeted Anti-cancer Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Targeted Anti-cancer Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, by Type, 2021 (%)
EGFR
ALK
Bcr-Abl
Others
Global Small Molecule Targeted Anti-cancer Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, by Application, 2021 (%)
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
Global Small Molecule Targeted Anti-cancer Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Targeted Anti-cancer Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Small Molecule Targeted Anti-cancer Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
